ProMIS Neurosciences, Inc. (PMN)
12.77
-1.20
(-8.62%)
USD |
NASDAQ |
Sep 03, 15:05
ProMIS Neurosciences 1 Year Total Returns (Daily) : 4.17% for Sept. 2, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 02, 2026 | 4.17% |
| September 01, 2026 | -1.09% |
| August 31, 2026 | -3.17% |
| August 28, 2026 | 4.93% |
| August 27, 2026 | 4.91% |
| August 26, 2026 | 5.36% |
| August 25, 2026 | 14.93% |
| August 24, 2026 | 10.47% |
| August 21, 2026 | 5.72% |
| August 20, 2026 | 13.62% |
| August 19, 2026 | 3.79% |
| August 18, 2026 | -2.88% |
| August 17, 2026 | -4.96% |
| August 14, 2026 | -5.65% |
| August 13, 2026 | -15.49% |
| August 12, 2026 | -17.14% |
| August 11, 2026 | -4.65% |
| August 10, 2026 | 4.40% |
| August 07, 2026 | 6.96% |
| August 06, 2026 | -9.63% |
| August 05, 2026 | -19.52% |
| August 04, 2026 | -22.58% |
| August 03, 2026 | -26.21% |
| July 31, 2026 | -28.83% |
| July 30, 2026 | -29.33% |
| Date | Value |
|---|---|
| July 29, 2026 | -33.06% |
| July 28, 2026 | -35.47% |
| July 27, 2026 | -52.48% |
| July 24, 2026 | -46.14% |
| July 23, 2026 | -42.68% |
| July 22, 2026 | -31.75% |
| July 21, 2026 | -48.25% |
| July 20, 2026 | 37.01% |
| July 17, 2026 | 29.25% |
| July 16, 2026 | 18.22% |
| July 15, 2026 | 27.32% |
| July 14, 2026 | 5.08% |
| July 13, 2026 | 31.15% |
| July 10, 2026 | 41.61% |
| July 09, 2026 | 45.58% |
| July 08, 2026 | 36.33% |
| July 07, 2026 | 32.65% |
| July 06, 2026 | 26.86% |
| July 02, 2026 | 19.20% |
| July 01, 2026 | 10.08% |
| June 30, 2026 | 8.81% |
| June 29, 2026 | -10.45% |
| June 26, 2026 | -13.14% |
| June 25, 2026 | -15.46% |
| June 24, 2026 | -15.55% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Edesa Biotech, Inc. | 103.3% |
| Arrowhead Pharmaceuticals, Inc. | 232.4% |
| Oncolytics Biotech, Inc. | -23.48% |
| Sangamo Therapeutics, Inc. | -68.30% |
| Sarepta Therapeutics, Inc. | 27.81% |